Stay updated on pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.

Latest updates to the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page
- Check5 days agoChange DetectedThe study page gains explicit tagging for Prostate cancer and a related topic entry for MedlinePlus Genetics. This links the content to disease-specific and genetics resources.SummaryDifference0.2%

- Check12 days agoChange DetectedNew help and navigation sections were added to the study page (How to Read a Study Record, Common Questions, How to Join a Study). A recruitment status note No longer looking for participants was added, and the Intervention/Treatment heading was reformatted, with an updated revision tag to v3.6.0.SummaryDifference0.4%

- Check19 days agoChange DetectedAdded a new protocol revision tag v3.5.5 and refreshed study record dates. Older revision/date entries (v3.5.4 and earlier dates) were removed.SummaryDifference0.3%

- Check27 days agoChange DetectedThe page no longer lists the condition 'Prostate cancer' and removes the related topics entry for 'MedlinePlus Genetics'.SummaryDifference0.2%

- Check41 days agoChange DetectedProstate cancer and related topics: MedlinePlus Genetics were added as related topics, and the revision note was updated from v3.5.3 to v3.5.4.SummaryDifference0.2%

- Check63 days agoChange DetectedThis update adjusts the ClinicalTrials.gov page footer revision/version text and removes/adds some surrounding MedlinePlus/related topics messaging. These are presentation or housekeeping elements and do not change the study content or the information participants would use to evaluate the trial.SummaryDifference0.2%

Stay in the know with updates to pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.